Nicolas A. Chronos, MD, FACC, FESC, FAHA, FRCP
President and Chief Executive Officer, Saint Joseph's Translational Research Institute, Georgia

Nicolas Chronos, MD, President and CEO, directs and oversees preclinical and clinical trials at SJTRI.

Dr. Chronos received a Bachelors degree in Medicine and Surgery from the Royal Free Hospital School of Medicine in London in 1987. Following, he trained in cardiology and subsequently interventional cardiology under the direction of Professors Ulrich Sigwart and Anthony Rickards at the Royal Brompton National Heart and Lung Institute.

In 1992, he was awarded a British Heart Foundation International Fellowship and moved to the United States to continue his research in thrombosis and interventional cardiology at Emory University School of Medicine under the direction of Spencer B. King, III, MD He was named Director of Research at the Andreas Gruentzig Cardiovascular Center at Emory University Hospital in 1997.

Dr. Chronos is a Fellow of the Royal College of Physicians (London), Fellow of the American College of Cardiology, Fellow of the European Society of Cardiology, and Fellow of the American Heart Association. He is a practicing Interventional Cardiologist for the Atlanta Cardiology Group (at Saint Joseph's Hospital of Atlanta), and is an Adjunct Professor of Cardiology and Medicine at Duke University.

For the National Institutes of Health, Dr. Chronos has served as Study Section Member and Chair for the Center for Scientific Review Cardiovascular Science, SBIR, and in June of 2006, he accepted an invitation to serve as a member of the NIH Recombinant DNA Advisory Committee. In addition, he has served on the Data Safety Monitoring Board (ClinTrials Research), NIRVANA (Boston Scientific), and SCORES (Scimed Life Systems). Dr. Chronos serves as a board member on multiple Scientific Advisory Boards including Medtronic Vascular, Bioheart, Inc., Symphony Medical, Inc., ViaCell, Inc. Atlanta Biotech Network, ACTx, Proteus Biomedical, and Celtaxsys, Inc. and has also served on the Steering Committees for various studies such as RFPMR (Boston Scientific), TARGET (Merck & Co., Inc.), and FIRST (Chiron Corporation).

World renowned for his pioneering research in angiogenesis, Dr. Chronos was named Co-National Principal Investigator with Professor Mike Simmons on the FIRST study, the largest human clinical trial of angiogenesis, and also presently serves as Principal Investigator for two large clinical trials that use autologous or umbilical cord stem cells to repair damaged cardiac muscle. His work on the MYOHEART (Myogenesis Heart Efficiency and Regeneration Trial) has received widespread media attention nationwide. Dr. Chronos has published over 200 peer-reviewed papers. His publications include articles in the Journal of the American College of Cardiology, Circulation, Heart and European Journal of Cardiology. He is an editorial consultant to the New England Journal of Medicine, British Heart Journal, Clinical Science, the Journal of the American College of Cardiology, Circulation, Heart, Atherosclerosis, Catheterization and Cardiovascular Interventions, Stent, Thrombosis Research, Cardiovascular Radiation Medicine, Journal of Stem Cells and Nature Medicine as well as other distinguished peer reviewed journals. He has over 100 abstracts and 17 book chapters published to date, and also serves as Editorial Consultant to many of the aforementioned publications.

As a faculty member and conference speaker at major conferences and meetings both nationally and internationally, Dr. Chronos is heavily sought after to share his intellectual and practical contributions in the field of cardiovascular medicine and research. In the same regard, he contributes and impacts the community in which he lives. As a caring physician and central force in research, Dr. Chronos is known for making a real impact on real people through close interaction among patients, physicians, scientists and industry.